Gregory Alan Korbel, SVP, Chief Business Officer at Aprea Therapeutics, Inc. (APRE), sold 27,500 shares at $5.00 ($138K) on 2021-11-01, disclosed to the SEC on 2021-11-03.
Open-market sale of $138k APRE by SVP, Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| APRE | SELL | 2021-09-22 | $164K | — | Filing → |
| APRE | BUY | 2019-10-07 | $8K | — | Filing → |